Columbus Macro’s iShares Biotechnology ETF IBB Stock Holding History

Columbus Macro’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.18M	Buy	+10,350	New	+$2.08M	0.21%	129
2026 Q2	–	Sell	-3,842	Closed	-$649K	–	209
2026 Q1	$649K	Sell	3,842 -14,983	-80%	-$2.56M	0.07%	155
2025 Q4	$3.18M	Buy	+18,825	New	+$3.06M	0.35%	95
2024 Q3	–	Sell	-10,271	Closed	-$1.41M	–	187
2024 Q2	$1.41M	Buy	+10,271	New	+$1.37M	0.55%	63
2023 Q1	–	Sell	-8,063	Closed	-$1.06M	–	171
2022 Q4	$1.06M	Buy	+8,063	New	+$1.04M	0.41%	84

Other funds holding IBB

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return

DRP

Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

Columbus Macro's IBB Position: Q3 2026 in Review

Columbus Macro opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 10,350 shares worth $2.18M. The stake represents 0.21% of the portfolio and ranks #129 among its holdings. This is a return to the name: Columbus Macro previously reported a position in IBB as recently as Q1 2026.

Columbus Macro first reported a position in IBB in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.18M in Q4 2025. 190 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Columbus Macro held 10,350 shares of iShares Biotechnology ETF worth $2.18M as of Q3 2026.
iShares Biotechnology ETF was a new Columbus Macro position in Q3 2026.
iShares Biotechnology ETF made up 0.21% of Columbus Macro's portfolio in Q3 2026, its #129 holding.
Columbus Macro first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 5 quarters since.
Columbus Macro's iShares Biotechnology ETF position peaked at $3.18M in Q4 2025.
190 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Columbus Macro's 13F filing for Q3 2026, filed 14 Oct 2026.